BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27146056)

  • 1. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
    Kim ES; Deeks ED
    Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin enacarbil: in patients with restless legs syndrome.
    Scott LJ
    CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
    VanMeter SA; Kavanagh ST; Warren S; Barrett RW
    CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin enacarbil in restless legs syndrome.
    Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
    Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
    Hayes WJ; Lemon MD; Farver DK
    Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
    Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
    Bogan RK; Bornemann MA; Kushida CA; TrĂ¢n PV; Barrett RW;
    Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
    Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
    Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
    Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
    Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
    Lee DO; Buchfuhrer MJ; Garcia-Borreguero D; Avidan AY; Ahmed M; Hays R; Ondo WG; Jaros MJ; Kim R; Shang G
    Sleep Med; 2016 Mar; 19():50-6. PubMed ID: 27198947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
    Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
    J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
    Burke RA; Faulkner MA
    Expert Opin Pharmacother; 2011 Dec; 12(18):2905-14. PubMed ID: 22077768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
    Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.
    Avidan AY; Lee D; Park M; Jaros MJ; Shang G; Kim R
    CNS Drugs; 2016 Apr; 30(4):305-16. PubMed ID: 27067343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin encarbil (Horizant) for restless leg syndrome.
    Med Lett Drugs Ther; 2011 Sep; 53(1372):70-1. PubMed ID: 21897349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
    Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
    Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
    Hermanowicz N; Ellenbogen A; Irving G; Buchfuhrer M; Jaros MJ; Shang G; Kim R
    CNS Drugs; 2016 May; 30(5):443-54. PubMed ID: 27095237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Tovera J; Lassauzet ML; Cundy KC
    J Clin Pharmacol; 2013 Jan; 53(1):29-40. PubMed ID: 23400741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New treatment options for the management of restless leg syndrome.
    Toro BE
    J Neurosci Nurs; 2014 Aug; 46(4):227-32. PubMed ID: 24992148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.